Search results
FDA approves new drug to treat autoimmune liver disease: ‘Giant step forward’
Fox News· 2 hours agoA new drug to control liver disease has gotten the green light. The U.S. Food and Drug...
FDA issues warning to Dollar Tree over its failure to remove recalled children's snack
FOX Business· 1 day agoThe U.S. Food and Drug Administration (FDA) sent a warning letter to Dollar Tree, Inc. last week...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 13 hours agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Sarepta’ stock soars 38% after FDA expands approval for DMD drug
Market Watch· 1 hour agoThere are about 15,000 cases in the U.S., according to the Muscular Dystrophy Association. The FDA...
Posts promoting unregistered weight loss pills share altered Myanmar FDA certificate
AFP via Yahoo News· 6 hours agoMyanmar's Food and Drug Administration (FDA) has not approved a purported weight-loss tablet that...
Arizona health officials, FDA report illnesses linked to Diamond Shruumz candy, chocolate, gummies
KSAZ via Yahoo News· 2 days agoSome people in Arizona have gotten sick after eating a brand of gummies, chocolate bars and candy,...
Chocolate supplier recalls over 4 million pounds due to salmonella
Consumer Affairs· 2 hours agoClasen Quality Chocolate, a supplier to food manufacturers and retailers, is recalling 4,383,201 pounds of chocolate goods because of potential salmonella contamination. The Madison, Wisc.-based ...
Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease
Pharmaceutical Technology via Yahoo Finance· 2 hours agoJohnson & Johnson (J&J) has submitted a supplemental biologics licence application (sBLA) seeking...
US FDA clears Kyverna’s KYV-101 cell therapy for Phase II SPS trial
Clinical Trials Arena via Yahoo Finance· 4 hours agoThe US Food and Drug Administration (FDA) has approved Kyverna Therapeutics’ Investigational New...
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
Investor's Business Daily· 2 hours agoSarepta stock rocketed early Friday after the Food and Drug Administration approved its Duchenne...